Financhill
Back

Lifecore Biomedical Quote, Financials, Valuation and Earnings

Sell
35

LFCR
Lifecore Biomedical

Last Price:
5.61
Seasonality Move:
3.46%

7 Day Trial

ALL ACCESS PASS

$ 7

Lifecore Biomedical Price Quote

$5.61
-0.08 (-1.41%)
(Updated: May 24, 2024 at 4:05 PM ET)

Lifecore Biomedical Key Stats

Sell
35
Lifecore Biomedical (LFCR) is a Sell

Day range:
$5.65 - $5.94
52-week range:
$4.50 - $11.46
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
0%

Volume:
240.4K
Avg. volume:
156.2K
1-year change:
-29.32%
Market cap:
$173.8M
Revenue:
$103.3M
EPS:
$-3.32

How Much Does Lifecore Biomedical Make?

Is Lifecore Biomedical Growing As A Company?

  • What Is Lifecore Biomedical's Growth Rate Quarterly?
    Quarterly YoY revenue growth is -0.67%
  • What Is Lifecore Biomedical's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Lifecore Biomedical Stock Price Performance

What Is Lifecore Biomedical 52-Week High & Low?

Lifecore Biomedical Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Lifecore Biomedical?

Is Lifecore Biomedical Cash Flow Positive?

  • What Is LFCR Cash Flow From Operations?
    Cash flow from operations (TTM) is -$34.5M
  • What Is Lifecore Biomedical’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $56.1M
  • What Is Lifecore Biomedical’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$4.2M

Lifecore Biomedical Return On Invested Capital

Data Unavailable

Lifecore Biomedical Earnings Date & Stock Price

Lifecore Biomedical Competitors

  • Who Are Lifecore Biomedical's Competitors?
    Below is a list of companies who compete with Lifecore Biomedical or are related in some way:
    • ADMA Biologics Inc (ADMA)
    • Aquestive Therapeutics Inc (AQST)
    • Jaguar Health Inc (JAGX)
    • Relmada Therapeutics Inc (RLMD)
    • SELLAS Life Sciences Group Inc (SLS)

Lifecore Biomedical Dividend Yield

Data Unavailable

Lifecore Biomedical Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -50.71%
Revenue: -67.02% 8.69%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 6.00
Upside from Last Price: 5.45%

Major Shareholders

  • How many LFCR shares are owned by institutional investors?
    26.9M LFCR shares are owned by institutional investors
  • How many LFCR shares are owned by insiders?
    2.3M LFCR shares are owned by insiders